Skip to main content
Premium Trial:

Request an Annual Quote

Venter to Consolidate TIGR, Four Non-Profits into Single Institute

Please click  here to read a corrected version of this article.

 

Washington, Sept. 27 (GenomeWeb News) - Craig Venter plans to merge the Institute for Genomic Research and four non-profit organizations that he currently directs into a single umbrella organization called the J. Craig Venter Institute, GenomeWeb News has learned.

 

Venter told GenomeWeb today at TIGR's annual GSAC meeting that the decision to consolidate the non-profit groups grew out of a need to streamline operational costs. The five groups currently each have separate boards, administrative operations, and other activities that will now be combined under the single institute.

 

"We did this so we could save some money and to make it easier to manage," Venter said.

 

The J. Craig Venter Institute will comprise TIGR, which Venter founded twelve years ago, and a group of non-profits that he launched in 2002: the J. Craig Venter Science Foundation, the Institute for Biological Energy Alternatives (IBEA), the Center for the Advancement of Genomics (TCAG), and the foundation's JointTechnologyCenter.

 

Venter said that the five groups together currently manage a grant portfolio of more than $100 million.

 

The new institute will employ approximately 500 people, Venter said, and no layoffs are expected.

 

Venter said the institute will provide further details of the consolidation tomorrow.

The Scan

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.

Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights

Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival.

CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood

A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system.

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.